MA27172A1 - 3-phenyl-5-alcoxy-1,3,4-oxdiazol-2-ones substitues, ainsi que leur production et leur utilisation dans des medicaments - Google Patents

3-phenyl-5-alcoxy-1,3,4-oxdiazol-2-ones substitues, ainsi que leur production et leur utilisation dans des medicaments

Info

Publication number
MA27172A1
MA27172A1 MA27803A MA27803A MA27172A1 MA 27172 A1 MA27172 A1 MA 27172A1 MA 27803 A MA27803 A MA 27803A MA 27803 A MA27803 A MA 27803A MA 27172 A1 MA27172 A1 MA 27172A1
Authority
MA
Morocco
Prior art keywords
oxdiazol
alcoxy
medicines
phenyl
production
Prior art date
Application number
MA27803A
Other languages
English (en)
Inventor
Karl Schoenafinger
Stefan Petry
Gunter Muller
Armin Bauer
Hubert Ott Heuer
Original Assignee
Aventis Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Gmbh filed Critical Aventis Pharma Gmbh
Publication of MA27172A1 publication Critical patent/MA27172A1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D271/00—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
    • C07D271/02—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
    • C07D271/10—1,3,4-Oxadiazoles; Hydrogenated 1,3,4-oxadiazoles
    • C07D271/113—1,3,4-Oxadiazoles; Hydrogenated 1,3,4-oxadiazoles with oxygen, sulfur or nitrogen atoms, directly attached to ring carbon atoms, the nitrogen atoms not forming part of a nitro radical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4245—Oxadiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Obesity (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Child & Adolescent Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Steroid Compounds (AREA)
MA27803A 2002-02-28 2004-07-27 3-phenyl-5-alcoxy-1,3,4-oxdiazol-2-ones substitues, ainsi que leur production et leur utilisation dans des medicaments MA27172A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE10208987A DE10208987A1 (de) 2002-02-28 2002-02-28 Substituierte 3-Phenyl-5-alkoxi-1,3,4-oxidiazol-2-one, ihre Herstellung und Verwendung in Arzneistoffen

Publications (1)

Publication Number Publication Date
MA27172A1 true MA27172A1 (fr) 2005-01-03

Family

ID=27740558

Family Applications (1)

Application Number Title Priority Date Filing Date
MA27803A MA27172A1 (fr) 2002-02-28 2004-07-27 3-phenyl-5-alcoxy-1,3,4-oxdiazol-2-ones substitues, ainsi que leur production et leur utilisation dans des medicaments

Country Status (22)

Country Link
EP (1) EP1480960B1 (fr)
JP (1) JP4486363B2 (fr)
KR (1) KR20040095240A (fr)
CN (1) CN1639137A (fr)
AR (1) AR038701A1 (fr)
AT (1) ATE557012T1 (fr)
AU (1) AU2003226977A1 (fr)
BR (1) BR0307921A (fr)
CA (1) CA2477031A1 (fr)
CO (1) CO5611146A2 (fr)
DE (1) DE10208987A1 (fr)
HR (1) HRP20040782A2 (fr)
HU (1) HUP0402671A3 (fr)
IL (1) IL163683A0 (fr)
MA (1) MA27172A1 (fr)
MX (1) MXPA04007960A (fr)
NO (1) NO20044090L (fr)
PE (1) PE20030928A1 (fr)
PL (1) PL370423A1 (fr)
RU (1) RU2004128933A (fr)
TW (1) TW200400951A (fr)
WO (1) WO2003072555A1 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7074822B2 (en) 2004-02-23 2006-07-11 Solvay Pharmaceuticals Gmbh Alkyl carbamate-substituted β-lactones, process for their preparation, and pharmaceutical compositions containing them
AU2005298692A1 (en) 2004-10-25 2006-05-04 Solvay Pharmaceuticals Gmbh Pharmaceutical compositions comprising CB1 cannabinoid receptor antagonists and potassium channel openers for the treatment of diabetes mellitus type I, obesity and related conditions
BRPI0821482A2 (pt) * 2007-12-27 2015-07-14 Bial Portela & Ca Sa 3-n-fenil-1,3,4-oxadiazolona 5-o-substituída, seu uso, sua composição e seu processo de preparação
AR074978A1 (es) 2008-12-23 2011-03-02 Bial Portela & Ca Sa 3-n-aril-1,3,4-oxadiazolonas 5-o-sustituidas para uso en el tratamiento del dolor y procedimiento de obtencion

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19942354A1 (de) * 1999-09-04 2001-03-08 Aventis Pharma Gmbh Substituierte 3-Phenyl-5-alkoxi-1,3,4-oxdiazol-2-one, ihre Herstellung und Verwendung in Arzneimitteln
RU2281283C2 (ru) * 2000-03-07 2006-08-10 Санофи-Авентис Дойчланд Гмбх Замещенные 3-фенил-5-алкокси-1,3,4-оксадиазол-2-оны и их применение для ингибирования гормоночувствительной липазы

Also Published As

Publication number Publication date
DE10208987A1 (de) 2003-09-11
ATE557012T1 (de) 2012-05-15
AR038701A1 (es) 2005-01-26
JP2005519085A (ja) 2005-06-30
CA2477031A1 (fr) 2003-09-04
HUP0402671A3 (en) 2006-07-28
IL163683A0 (en) 2005-12-18
NO20044090L (no) 2004-11-04
WO2003072555A1 (fr) 2003-09-04
JP4486363B2 (ja) 2010-06-23
MXPA04007960A (es) 2004-11-26
KR20040095240A (ko) 2004-11-12
AU2003226977A1 (en) 2003-09-09
BR0307921A (pt) 2004-12-21
PE20030928A1 (es) 2003-12-17
EP1480960B1 (fr) 2012-05-09
HRP20040782A2 (en) 2005-02-28
PL370423A1 (en) 2005-05-30
HUP0402671A2 (hu) 2005-04-28
EP1480960A1 (fr) 2004-12-01
CO5611146A2 (es) 2006-02-28
CN1639137A (zh) 2005-07-13
RU2004128933A (ru) 2005-04-20
TW200400951A (en) 2004-01-16

Similar Documents

Publication Publication Date Title
PT1095025E (pt) Benzimidazoles sua producao e sua utilizacao como medicamentos
PT1362027E (pt) 6,7,8,9-tetra-hidro-5h-benzociclo-heptenilaminas aciladas e a sua utilização como fármacos
CY2015009PI1 (el) Ινδολινονες υποκατεστημενες στη θεση 6, η παραγωγη αυτων και η χρηση αυτων ως φαρμακευτικα μεσα
AU2003292239A8 (en) Novel carboxamides, the production and use thereof as medicaments
ATE432919T1 (de) Azetidinderivate, ihre herstellung und sie enthaltende pharmazeutische zusammensetzungen
AU2003293757A1 (en) Novel substituted imidazo-pyridinones and imidazo-pyridazeiones, the production and use thereof as medicaments
EE200300311A (et) Ftalasinoon-piperidinoderivaadid, nende kasutamine ja ravim
IS7564A (is) Lyfjablanda með breytta losun
EP1513825A4 (fr) Medicament anti-tuberculeux: compositions et methodes
PT1500654E (pt) Derivados de benzoxazinona, sua preparacao e utilizacao como medicamentos
LV12624B (lv) Tienilazolilalkosietanamini to iegusanas panemiens un pielietojums medikamentu legusana
IL149400A0 (en) Indeno-, naphtho-, and benzocyclohepta-dihydrothiazole derivatives, the production thereof and their use as anorectic medicaments
PL374420A1 (pl) Proces wytwarzania kompozytu z kopolimeru blokowego i leku
ZA200604432B (en) Thiozolidinones production and use thereof as medicaments
PL374879A1 (en) Indoline derivatives substituted in position 6, production and use thereof as medicaments
EP1750693A4 (fr) Medicaments et promedicaments oculoselectifs
MA27172A1 (fr) 3-phenyl-5-alcoxy-1,3,4-oxdiazol-2-ones substitues, ainsi que leur production et leur utilisation dans des medicaments
FR2870539B1 (fr) Nouvelles methodes et medicaments
BR0314139A (pt) Derivados de 1,4-pirazina substituìdos
ATE487741T1 (de) Mischungen aus von heparin abgeleiteten oligosacchariden, herstellung davon und pharmazeutische zusammensetzungen, die die mischungen enthalten
IL155853A0 (en) Substituted cyclohexane derivatives and the use thereof in medicaments for treating cardiovascular diseases
AU2003254556A1 (en) Indoline derivatives substituted in position 6, production and use thereof as medicaments
EP1745000A4 (fr) Nouvelles anthraquinones et leur procede de preparation et d'utilisation
HRP20040691A2 (en) 2'-halo-3',5'-dialkoxyphen-1'-yl-imino-2-imidazolidine and the use thereof as a drug
PT1235809E (pt) 1,2,3,4,5,6-hexa-hidro-2,6-metano-3-benzazocinas substituidas e sua utilizacao como medicamentos